{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:01:12Z","timestamp":1755223272071,"version":"3.43.0"},"reference-count":69,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"DOI":"10.31744\/einstein_journal\/2025ao1601","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:00:36Z","timestamp":1754924436000},"source":"Crossref","is-referenced-by-count":0,"title":["Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-9302","authenticated-orcid":false,"given":"Karina Serafim da","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3021-722X","authenticated-orcid":false,"given":"Vanessa Ribeiro","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-1624","authenticated-orcid":false,"given":"Feres Camargo","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-9193","authenticated-orcid":false,"given":"Gabriel Arantes dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-3798","authenticated-orcid":false,"given":"Juliana Alves de","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-790X","authenticated-orcid":false,"given":"Iran Amorim da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2615-7730","authenticated-orcid":false,"given":"Katia Ramos Moreira","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3564-3597","authenticated-orcid":false,"given":"Sabrina Thalita dos","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-8508","authenticated-orcid":false,"given":"Nayara Izabel","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-0596","authenticated-orcid":false,"given":"Miguel","family":"Srougi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3423-5647","authenticated-orcid":false,"given":"Ruan","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"2","key":"key20250811150031_B1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","unstructured":"1. Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18(2):79-92.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"key20250811150031_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-004-0473-1","article-title":"Mechanisms of the development of androgen independence in prostate cancer","volume":"23","author":"So","year":"2005","unstructured":"2. So A, Gleave M, Hurtado-Col A, Nelson C. Mechanisms of the development of androgen independence in prostate cancer. World J Urol. 2005 Feb;23(1):1-9.","journal-title":"World J Urol"},{"issue":"6","key":"key20250811150031_B3","first-page":"1086","article-title":"Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP","volume":"57","author":"Swinnen","year":"1997","unstructured":"3. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 1997;57(6):1086-90.","journal-title":"Cancer Res"},{"key":"key20250811150031_B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.04.016","article-title":"Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer","volume":"191","author":"Gonthier","year":"2019","unstructured":"4. Gonthier K, Poluri RT, Audet-Walsh \u00c9. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2019;191:105367.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"key20250811150031_B5","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/ERC-15-0556","article-title":"Androgen control of lipid metabolism in prostate cancer: novel insights and future applications","volume":"23","author":"Butler","year":"2016","unstructured":"5. Butler LM, Centenera MM, Swinnen JV. Androgen control of lipid metabolism in prostate cancer: novel insights and future applications. Endocr Relat Cancer. 2016;23(5):R219-27.","journal-title":"Endocr Relat Cancer"},{"key":"key20250811150031_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33594\/000000592","article-title":"Cholesterol Triggers Nuclear Co-Association of Androgen Receptor, p160 Steroid Coactivators, and p300\/CBP-Associated Factor Leading to Androgenic Axis Transactivation in Castration-Resistant Prostate Cancer","volume":"56","author":"Pimenta","year":"2022","unstructured":"6. Pimenta R, Camargo JA, Candido P, Ghazarian V, Gon\u00e7alves GL, Guimar\u00e3es VR, et al. Cholesterol Triggers Nuclear Co-Association of Androgen Receptor, p160 Steroid Coactivators, and p300\/CBP-Associated Factor Leading to Androgenic Axis Transactivation in Castration-Resistant Prostate Cancer. Cell Physiol Biochem. 2022;56 S4:1-15.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"key20250811150031_B7","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318803011","article-title":"MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line","volume":"40","author":"Pimenta","year":"2018","unstructured":"7. Pimenta RC, Viana NI, Amaral GQ, Park R, Morais DR, Pontes J Jr, et al. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. Tumour Biol. 2018;40(11):1010428318803011.","journal-title":"Tumour Biol"},{"issue":"4","key":"key20250811150031_B8","first-page":"149","article-title":"Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer?","volume":"10","author":"de Moraes","year":"2021","unstructured":"8. de Moraes RP, Pimenta R, Mori FN, Dos Santos GA, Viana NI, Guimar\u00e3es VR, et al. Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer? Mol Biol Res Commun. 2021;10(4):149-56.","journal-title":"Mol Biol Res Commun"},{"issue":"9","key":"key20250811150031_B9","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1007\/s11033-023-08638-4","article-title":"Overexpression of miR-17-5p may negatively impact p300\/CBP factor-associated inflammation in a hypercholesterolemic advanced prostate cancer model","volume":"50","author":"Pimenta","year":"2023","unstructured":"9. Pimenta R, Camargo JA, Gon\u00e7alves GL, Ghazarian V, Candido P, Guimar\u00e3es VR, et al. Overexpression of miR-17-5p may negatively impact p300\/CBP factor-associated inflammation in a hypercholesterolemic advanced prostate cancer model. Mol Biol Rep. 2023;50(9):7333-45.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"key20250811150031_B10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.23452","article-title":"Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer","volume":"78","author":"Cheng","year":"2018","unstructured":"10. Cheng HH, Plets M, Li H, Higano CS, Tangen CM, Agarwal N, et al. Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer. Prostate. 2018;78(2):121-7.","journal-title":"Prostate"},{"issue":"8","key":"key20250811150031_B11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/bjc.2017.50","article-title":"Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer","volume":"116","author":"Lin","year":"2017","unstructured":"11. Lin HM, Mahon KL, Spielman C, Gurney H, Mallesara G, Stockler MR, et al. Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer. Br J Cancer. 2017;116(8):1002-11.","journal-title":"Br J Cancer"},{"issue":"10","key":"key20250811150031_B12","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1078-0432.CCR-23-2748","article-title":"Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer","volume":"30","author":"Hedayat","year":"2024","unstructured":"12. Hedayat S, Cascione L, Cunningham D, Schirripa M, Lampis A, Hahne JC, et al. Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. Clin Cancer Res. 2024;30(10):2140-59.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"key20250811150031_B13","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1007\/s11033-020-05918-1","article-title":"Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line","volume":"47","author":"Deezagi","year":"2020","unstructured":"13. Deezagi A, Safari N. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line. Mol Biol Rep. 2020;47(11):8727-37.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"key20250811150031_B14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-07-0531","article-title":"Statin induces apoptosis and cell growth arrest in prostate cancer cells","volume":"17","author":"Hoque","year":"2008","unstructured":"14. Hoque A, Chen H, Xu XC. Statin induces apoptosis and cell growth arrest in prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2008;17(1):88-94.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"key20250811150031_B15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119633","article-title":"Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137\/Coactivator p160\/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer","volume":"24","author":"Pimenta","year":"2023","unstructured":"15. Pimenta R, Mioshi CM, Gon\u00e7alves GL, Candido P, Camargo JA, Guimar\u00e3es VR, et al. Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137\/Coactivator p160\/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer. Int J Mol Sci. 2023;24(11):9633.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"key20250811150031_B16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112626","article-title":"Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy","volume":"20","author":"Stoykova","year":"2019","unstructured":"16. Stoykova GE, Schlaepfer IR. Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy. Int J Mol Sci. 2019;20(11):2626.","journal-title":"Int J Mol Sci"},{"key":"key20250811150031_B17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","unstructured":"17. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18-27.","journal-title":"Neoplasia"},{"issue":"4","key":"key20250811150031_B18","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.722","article-title":"Using the Reactome Database","volume":"3","author":"Rothfels","year":"2023","unstructured":"18. Rothfels K, Milacic M, Matthews L, Haw R, Sevilla C, Gillespie M, et al. Using the Reactome Database. Curr Protoc. 2023;3(4):e722.","journal-title":"Curr Protoc"},{"issue":"22","key":"key20250811150031_B19","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1093\/nar\/gks901","article-title":"MiRmap: comprehensive prediction of microRNA target repression strength","volume":"40","author":"Vejnar","year":"2012","unstructured":"19. Vejnar CE, Zdobnov EM. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 2012;40(22):11673-83.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250811150031_B20","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","unstructured":"20. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48 D1:D127-31.","journal-title":"Nucleic Acids Res"},{"key":"key20250811150031_B21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","unstructured":"21. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:4.","journal-title":"eLife"},{"issue":"1","key":"key20250811150031_B22","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-016-1281-5","article-title":"VennDiagramWeb: a web application for the generation of highly customizable Venn and Euler diagrams","volume":"17","author":"Lam","year":"2016","unstructured":"22. Lam F, Lalansingh CM, Babaran HE, Wang Z, Prokopec SD, Fox NS, et al. VennDiagramWeb: a web application for the generation of highly customizable Venn and Euler diagrams. BMC Bioinformatics. 2016;17(1):401.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"key20250811150031_B23","doi-asserted-by":"crossref","first-page":"D246","DOI":"10.1093\/nar\/gkx1158","article-title":"Expression Atlas: gene and protein expression across multiple studies and organisms","volume":"46","author":"Papatheodorou","year":"2018","unstructured":"23. Papatheodorou I, Fonseca NA, Keays M, Tang YA, Barrera E, Bazant W, et al. Expression Atlas: gene and protein expression across multiple studies and organisms. Nucleic Acids Res. 2018;46 D1:D246-51.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250811150031_B24","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","unstructured":"24. Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2022;50 D1:D1334-9.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"key20250811150031_B25","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","unstructured":"25. Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47 W1:W556-60.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250811150031_B26","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","unstructured":"26. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51 D1:D587-92.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"key20250811150031_B27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","unstructured":"27. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25-9.","journal-title":"Nat Genet"},{"issue":"1","key":"key20250811150031_B28","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyad031","article-title":"The Gene Ontology knowledgebase in 2023","volume":"224","author":"Gene Ontology Consortium","year":"2023","unstructured":"28. Gene Ontology Consortium; Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL, Hill DP, Lee R, Mi H, Moxon S, Mungall CJ, Muruganugan A, Mushayahama T, Sternberg PW, Thomas PD, Van Auken K, Ramsey J, Siegele DA, Chisholm RL, Fey P, Aspromonte MC, Nugnes MV, Quaglia F, Tosatto S, Giglio M, Nadendla S, Antonazzo G, Attrill H, Dos Santos G, Marygold S, Strelets V, Tabone CJ, Thurmond J, Zhou P, Ahmed SH, Asanitthong P, Luna Buitrago D, Erdol MN, Gage MC, Ali Kadhum M, Li KYC, Long M, Michalak A, Pesala A, Pritazahra A, Saverimuttu SCC, Su R, Thurlow KE, Lovering RC, Logie C, Oliferenko S, Blake J, Christie K, Corbani L, Dolan ME, Drabkin HJ, Hill DP, Ni L, Sitnikov D, Smith C, Cuzick A, Seager J, Cooper L, Elser J, Jaiswal P, Gupta P, Jaiswal P, Naithani S, Lera-Ramirez M, Rutherford K, Wood V, De Pons JL, Dwinell MR, Hayman GT, Kaldunski ML, Kwitek AE, Laulederkind SJF, Tutaj MA, Vedi M, Wang SJ, D\u2019Eustachio P, Aimo L, Axelsen K, Bridge A, Hyka-Nouspikel N, Morgat A, Aleksander SA, Cherry JM, Engel SR, Karra K, Miyasato SR, Nash RS, Skrzypek MS, Weng S, Wong ED, Bakker E, Berardini TZ, Reiser L, Auchincloss A, Axelsen K, Argoud-Puy G, Blatter MC, Boutet E, Breuza L, Bridge A, Casals-Casas C, Coudert E, Estreicher A, Livia Famiglietti M, Feuermann M, Gos A, Gruaz-Gumowski N, Hulo C, Hyka-Nouspikel N, Jungo F, Le Mercier P, Lieberherr D, Masson P, Morgat A, Pedruzzi I, Pourcel L, Poux S, Rivoire C, Sundaram S, Bateman A, Bowler-Barnett E, Bye-A-Jee H, Denny P, Ignatchenko A, Ishtiaq R, Lock A, Lussi Y, Magrane M, Martin MJ, Orchard S, Raposo P, Speretta E, Tyagi N, Warner K, Zaru R, Diehl AD, Lee R, Chan J, Diamantakis S, Raciti D, Zarowiecki M, Fisher M, James-Zorn C, Ponferrada V, Zorn A, Ramachandran S, Ruzicka L, Westerfield M. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224(1):iyad031.","journal-title":"Genetics"},{"issue":"D1","key":"key20250811150031_B29","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","unstructured":"29. Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638-46.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"key20250811150031_B30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2016.07.033","article-title":"Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response","volume":"71","author":"Ylitalo","year":"2017","unstructured":"30. Ylitalo EB, Thysell E, Jernberg E, Lundholm M, Crnalic S, Egevad L, et al. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. Eur Urol. 2017;71(5):776-87.","journal-title":"Eur Urol"},{"issue":"34","key":"key20250811150031_B31","doi-asserted-by":"crossref","first-page":"35710","DOI":"10.18632\/oncotarget.5958","article-title":"MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators","volume":"6","author":"Nilsson","year":"2015","unstructured":"31. Nilsson EM, Laursen KB, Whitchurch J, McWilliam A, \u00d8dum N, Persson JL, et al. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators. Oncotarget. 2015;6(34):35710-25.","journal-title":"Oncotarget"},{"issue":"6","key":"key20250811150031_B32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039102","article-title":"MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells","volume":"7","author":"Zhao","year":"2012","unstructured":"32. Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, et al. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One. 2012;7(6):e39102.","journal-title":"PLoS One"},{"issue":"8","key":"key20250811150031_B33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/me.2015-1080","article-title":"miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation","volume":"29","author":"Eedunuri","year":"2015","unstructured":"33. Eedunuri VK, Rajapakshe K, Fiskus W, Geng C, Chew SA, Foley C, et al. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation. Mol Endocrinol. 2015;29(8):1170-83.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"key20250811150031_B34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1159\/000358650","article-title":"miR-137 controls proliferation and differentiation of human adipose tissue stromal cells","volume":"33","author":"Shin","year":"2014","unstructured":"34. Shin KK, Kim YS, Kim JY, Bae YC, Jung JS. miR-137 controls proliferation and differentiation of human adipose tissue stromal cells. Cell Physiol Biochem. 2014;33(3):758-68.","journal-title":"Cell Physiol Biochem"},{"issue":"28","key":"key20250811150031_B35","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/onc.2013.330","article-title":"miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells","volume":"33","author":"Takwi","year":"2014","unstructured":"35. Takwi AA, Wang YM, Wu J, Michaelis M, Cinatl J, Chen T. miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene. 2014;33(28):3717-29.","journal-title":"Oncogene"},{"issue":"5","key":"key20250811150031_B36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-18-1147","article-title":"Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis","volume":"17","author":"Tousignant","year":"2019","unstructured":"36. Tousignant KD, Rockstroh A, Taherian Fard A, Lehman ML, Wang C, McPherson SJ, et al. Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis. Mol Cancer Res. 2019;17(5):1166-79.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"key20250811150031_B37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/1055-9965.EPI-18-0079","article-title":"Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study","volume":"28","author":"Adams","year":"2019","unstructured":"37. Adams CD, Richmond R, Ferreira DLS, Spiller W, Tan V, Zheng J, W\u00fcrtz P, Donovan J, Hamdy F, Neal D, Lane JA, Smith GD, Relton C, Eeles RA, Haiman CA, Kote-Jarai Z, Schumacher FR, Olama AAA, Benlloch S, Muir K, Berndt SI, Conti DV, Wiklund F, Chanock SJ, Gapstur S, Stevens VL, Tangen CM, Batra J, Clements JA, Gronberg H, Pashayan N, Schleutker J, Albanes D, Wolk A, West CML, Mucci LA, Cancel-Tassin G, Koutros S, Sorensen KD, Maehle L, Travis RC, Hamilton RJ, Ingles SA, Rosenstein BS, Lu YJ, Giles GG, Kibel AS, Vega A, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, John EM, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva RP, Usmani N, Claessens F, Townsend PA, Dominguez MG, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Martin RM; PRACTICAL consortium. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiol Biomarkers Prev. 2019;28(1):208-16.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"key20250811150031_B38","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1210\/endo.137.10.8828509","article-title":"Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP","volume":"137","author":"Swinnen","year":"1996","unstructured":"38. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology. 1996;137(10):4468-74.","journal-title":"Endocrinology"},{"issue":"4","key":"key20250811150031_B39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsbmb.2004.10.013","article-title":"Androgens, lipogenesis and prostate cancer","volume":"92","author":"Swinnen","year":"2004","unstructured":"39. Swinnen JV, Heemers H, van de Sande T, de Schrijver E, Brusselmans K, Heyns W, et al. Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol. 2004;92(4):273-9.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"key20250811150031_B40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajur.2019.12.003","article-title":"Lipogenic effects of androgen signaling in normal and malignant prostate","volume":"7","author":"Mah","year":"2020","unstructured":"40. Mah CY, Nassar ZD, Swinnen JV, Butler LM. Lipogenic effects of androgen signaling in normal and malignant prostate. Asian J Urol. 2020;7(3):258-70.","journal-title":"Asian J Urol"},{"issue":"1","key":"key20250811150031_B41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/me.2009-0302","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR","volume":"24","author":"Shiota","year":"2010","unstructured":"41. Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, et al. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol. 2010;24(1):114-27.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"key20250811150031_B42","article-title":"Identification of Differentially Expressed MicroRNAs and Their Potential Target Genes in Adipose Tissue from Pigs with Highly Divergent Backfat Thickness","volume":"10","author":"Xing","year":"2020","unstructured":"42. Xing K, Zhao X, Liu Y, Zhang F, Tan Z, Qi X, et al. Identification of Differentially Expressed MicroRNAs and Their Potential Target Genes in Adipose Tissue from Pigs with Highly Divergent Backfat Thickness. Animals (Basel). 2020;10(4):624.","journal-title":"Animals (Basel)"},{"issue":"9","key":"key20250811150031_B43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc2695","article-title":"Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family","volume":"9","author":"Xu","year":"2009","unstructured":"43. Xu J, Wu RC, O'Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9(9):615-30.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"key20250811150031_B44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","unstructured":"44. Bonkhoff H. Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression. Prostate. 2018;78(1):2-10.","journal-title":"Prostate"},{"issue":"11","key":"key20250811150031_B45","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/ijc.22363","article-title":"Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer","volume":"120","author":"Fujimura","year":"2007","unstructured":"45. Fujimura T, Takahashi S, Urano T, Kumagai J, Ogushi T, Horie-Inoue K, et al. Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer. Int J Cancer. 2007;120(11):2325-30.","journal-title":"Int J Cancer"},{"issue":"6","key":"key20250811150031_B46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/onc.2017.385","article-title":"Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer","volume":"37","author":"Han","year":"2018","unstructured":"46. Han W, Gao S, Barrett D, Ahmed M, Han D, Macoska JA, et al. Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer. Oncogene. 2018;37(6):710-21.","journal-title":"Oncogene"},{"key":"key20250811150031_B47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00525","article-title":"Cholesterol as an Endogenous ERRa Agonist: A New Perspective to Cancer Treatment","volume":"9","author":"Casaburi","year":"2018","unstructured":"47. Casaburi I, Chimento A, De Luca A, Nocito M, Sculco S, Avena P, et al. Cholesterol as an Endogenous ERRa Agonist: A New Perspective to Cancer Treatment. Front Endocrinol (Lausanne). 2018;9:525.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"key20250811150031_B48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/epi-2017-0141","article-title":"Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohort","volume":"10","author":"Kresovich","year":"2018","unstructured":"48. Kresovich JK, Joyce BT, Gao T, Zheng Y, Zhang Z, Achenbach CJ, et al. Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohort. Epigenomics. 2018;10(6):733-43.","journal-title":"Epigenomics"},{"issue":"7334","key":"key20250811150031_B49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09787","article-title":"Telomere dysfunction induces metabolic and mitochondrial compromise","volume":"470","author":"Sahin","year":"2011","unstructured":"49. Sahin E, Colla S, Liesa M, Moslehi J, M\u00fcller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470(7334):359-65.","journal-title":"Nature"},{"issue":"2","key":"key20250811150031_B50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP","volume":"120","author":"Lin","year":"2005","unstructured":"50. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 2005;120(2):261-73.","journal-title":"Cell"},{"issue":"1","key":"key20250811150031_B51","doi-asserted-by":"crossref","DOI":"10.1186\/s43046-021-00082-4","article-title":"Prognostic value of TERF1 expression in prostate cancer","volume":"33","author":"Dos Santos","year":"2021","unstructured":"51. Dos Santos GA, Viana NI, Pimenta R, Guimar\u00e3es VR, de Camargo JA, Rom\u00e3o P, et al. Prognostic value of TERF1 expression in prostate cancer. J Egypt Natl Canc Inst. 2021;33(1):24.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"17","key":"key20250811150031_B52","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1158\/0008-5472.CAN-04-4076","article-title":"SRC-3 is required for prostate cancer cell proliferation and survival","volume":"65","author":"Zhou","year":"2005","unstructured":"52. Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005;65(17):7976-83.","journal-title":"Cancer Res"},{"issue":"21","key":"key20250811150031_B53","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1158\/0008-5472.CAN-06-1023","article-title":"Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer","volume":"66","author":"Agoulnik","year":"2006","unstructured":"53. Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, et al. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res. 2006; 66(21):10594-602.","journal-title":"Cancer Res"},{"issue":"2","key":"key20250811150031_B54","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-023-05598-x","article-title":"Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression","volume":"150","author":"Pimenta","year":"2024","unstructured":"54. Pimenta R, Malulf FC, Rom\u00e3o P, Caetano GV, da Silva KS, Ghazarian V, et al. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. J Cancer Res Clin Oncol. 2024;150(2):70.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"key20250811150031_B55","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI76029","article-title":"Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis","volume":"125","author":"Dasgupta","year":"2015","unstructured":"55. Dasgupta S, Putluri N, Long W, Zhang B, Wang J, Kaushik AK, et al. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J Clin Invest. 2015;125(3):1174-88.","journal-title":"J Clin Invest"},{"issue":"5","key":"key20250811150031_B56","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00216-006-1093-y","article-title":"Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study","volume":"387","author":"Gazi","year":"2007","unstructured":"56. Gazi E, Dwyer J, Lockyer NP, Gardner P, Shanks JH, Roulson J, et al. Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study. Anal Bioanal Chem. 2007;387(5):1621-31.","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"key20250811150031_B57","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.bjc.6603030","article-title":"Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs","volume":"94","author":"Brown","year":"2006","unstructured":"57. Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer. 2006;94(6):842-53.","journal-title":"Br J Cancer"},{"issue":"11","key":"key20250811150031_B58","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.18632\/oncotarget.1482","article-title":"Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms","volume":"4","author":"Herroon","year":"2013","unstructured":"58. Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, et al. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget. 2013;4(11):2108-23.","journal-title":"Oncotarget"},{"issue":"2","key":"key20250811150031_B59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00223-017-0350-8","article-title":"Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis","volume":"102","author":"Park","year":"2018","unstructured":"59. Park SH, Keller ET, Shiozawa Y. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int. 2018;102(2):152-62.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"key20250811150031_B60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014175","article-title":"Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol","volume":"5","author":"Thysell","year":"2010","unstructured":"60. Thysell E, Surowiec I, H\u00f6rnberg E, Crnalic S, Widmark A, Johansson AI, et al. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS One. 2010;5(12):e14175.","journal-title":"PLoS One"},{"issue":"3","key":"key20250811150031_B61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","unstructured":"61. Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014;19(3):393-406.","journal-title":"Cell Metab"},{"issue":"1-2","key":"key20250811150031_B62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0303-7207(02)00363-5","article-title":"Androgen biosynthesis from cholesterol to DHEA","volume":"198","author":"Miller","year":"2002","unstructured":"62. Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002;198(1-2):7-14.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"key20250811150031_B63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.201004026","article-title":"Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis","volume":"192","author":"Hartig","year":"2011","unstructured":"63. Hartig SM, He B, Long W, Buehrer BM, Mancini MA. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J Cell Biol. 2011; 192(1):55-67.","journal-title":"J Cell Biol"},{"issue":"4","key":"key20250811150031_B64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1210\/me.2015-1005","article-title":"Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism","volume":"29","author":"Rollins","year":"2015","unstructured":"64. Rollins DA, Coppo M, Rogatsky I. Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism. Mol Endocrinol. 2015;29(4):502-17.","journal-title":"Mol Endocrinol"},{"issue":"8","key":"key20250811150031_B65","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.M700131-JLR200","article-title":"Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy","volume":"48","author":"Gazi","year":"2007","unstructured":"65. Gazi E, Gardner P, Lockyer NP, Hart CA, Brown MD, Clarke NW. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res. 2007;48(8):1846-56.","journal-title":"J Lipid Res"},{"issue":"10","key":"key20250811150031_B66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2021.194734","article-title":"MicroRNAs mediated regulation of glutathione peroxidase 7 expression and its changes during adipogenesis","volume":"1864","author":"Hanouskov\u00e1","year":"2021","unstructured":"66. Hanouskov\u00e1 B, V\u00e1vrov\u00e1 G, Ambro\u017e M, Bou\u0161ov\u00e1 I, Karlsen TA, Sk\u00e1lov\u00e1 L, et al. MicroRNAs mediated regulation of glutathione peroxidase 7 expression and its changes during adipogenesis. Biochim Biophys Acta Gene Regul Mech. 2021;1864(10):194734.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"3","key":"key20250811150031_B67","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2021-0332","article-title":"MiR-137-mediated negative relationship between LGR4 and RANKL modulated osteogenic differentiation of human adipose-derived mesenchymal stem cells","volume":"45","author":"Fan","year":"2022","unstructured":"67. Fan C, Li Y. MiR-137-mediated negative relationship between LGR4 and RANKL modulated osteogenic differentiation of human adipose-derived mesenchymal stem cells. Genet Mol Biol. 2022;45(3):e20210322.","journal-title":"Genet Mol Biol"},{"issue":"1","key":"key20250811150031_B68","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02495-3","article-title":"A NOTCH1\/LSD1\/BMP2 co-regulatory network mediated by miR-137 negatively regulates osteogenesis of human adipose-derived stem cells","volume":"12","author":"Fan","year":"2021","unstructured":"68. Fan C, Ma X, Wang Y, Lv L, Zhu Y, Liu H, et al. A NOTCH1\/LSD1\/BMP2 co-regulatory network mediated by miR-137 negatively regulates osteogenesis of human adipose-derived stem cells. Stem Cell Res Ther. 2021;12(1):417.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"key20250811150031_B69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jcp.29006","article-title":"MiR-137 knockdown promotes the osteogenic differentiation of human adipose-derived stem cells via the LSD1\/BMP2\/SMAD4 signaling network","volume":"235","author":"Ma","year":"2020","unstructured":"69. Ma X, Fan C, Wang Y, Du Y, Zhu Y, Liu H, et al. MiR-137 knockdown promotes the osteogenic differentiation of human adipose-derived stem cells via the LSD1\/BMP2\/SMAD4 signaling network. J Cell Physiol. 2020; 235(2):909-19.","journal-title":"J Cell Physiol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:00:43Z","timestamp":1754924443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/interconnected-study-of-molecular-pathways-mir-137-as-a-central-element-at-the-intersection-of-lipid-metabolism-and-prostate-carcinogenesis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":69,"alternative-id":["10.31744\/einstein_journal\/2025AO1601"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025ao1601","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eAO1601"}}